adverse drug reaction (ADR) 第1页

Reevaluation on adverse reaction monitoring and safety of proprietary Chinese medicines of Chongqing from 2005 to 2011 “Re-evaluation upon suspected event” is an approach for post-marketing clinical study： lessons from adverse drug events related to Bupleuri Radix preparations Probe of early prediction methods for adverse drug reaction and quality fluctuation in Chinese materia medica injection